Ranked #817 of 8,699 institutional investors
Bellevue Group AG
Zurich, V8
$5.03B
US stock portfolio at live prices · today −$800K (−0.02%)
Market closed. Prices as of Nov 20, 7:41 AM ET
- Value at quarter end (Q3 2026)
- $4.82B
- Change from Q2 2026
- +$67.2M (+1.41%)
- Positions
- 141 · 20 new, 14 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$178M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesAMGN 7.52%GILD 7.12%VRTX 5.99%ARGX 5.44%REGN 5.13%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| AMGN Amgen Inc. | 861,690 | $378M | 7.52% | Added +1% |
| GILD Gilead Sciences, Inc. | 2,150,692 | $358M | 7.12% | Reduced −0% |
| VRTX Vertex Pharmaceuticals Incorporated | 578,532 | $301M | 5.99% | Unchanged |
| ARGX argenx SE | 290,507 | $274M | 5.44% | Reduced −3% |
| REGN Regeneron Pharmaceuticals, Inc. | 279,590 | $258M | 5.13% | Added +78% |
| VRDN Viridian Therapeutics, Inc. | 7,109,318 | $224M | 4.44% | Added +6% |
| INSM Insmed Incorporated | 1,508,034 | $218M | 4.33% | Added +8% |
| ORKA Oruka Therapeutics, Inc. | 1,641,059 | $160M | 3.18% | Reduced −1% |
| RVMD Revolution Medicines, Inc. | 998,950 | $159M | 3.17% | Reduced −5% |
| BIIB Biogen Inc. | 597,924 | $148M | 2.94% | Added +176,801% |
| SRRK Scholar Rock Holding Corporation | 2,786,925 | $140M | 2.79% | Added +14% |
| PCVX Vaxcyte, Inc. | 2,322,401 | $136M | 2.69% | Added +18% |
| ABT Abbott Laboratories | 1,047,927 | $109M | 2.16% | Added +11% |
| UTHR United Therapeutics Corporation | 186,429 | $104M | 2.07% | Reduced −1% |
| ISRG Intuitive Surgical, Inc. | 248,002 | $101M | 2.01% | Reduced −3% |
| RLAY Relay Therapeutics, Inc. | 6,185,970 | $98.4M | 1.96% | Unchanged |
| BBIO BridgeBio Pharma, Inc. | 1,196,669 | $93.6M | 1.86% | Added +1% |
| ELVN Enliven Therapeutics, Inc. | 1,469,000 | $68.2M | 1.36% | Reduced −1% |
| JBIO Jade Biosciences, Inc. | 4,293,937 | $64.7M | 1.29% | Added +40% |
| EW Edwards Lifesciences Corporation | 587,729 | $61.1M | 1.21% | Reduced −20% |
| IMCR Immunocore Holdings plc | 2,264,321 | $60.3M | 1.20% | Reduced −19% |
| DXCM DexCom, Inc. | 741,875 | $59.5M | 1.18% | Reduced −10% |
| SYK Stryker Corporation | 185,366 | $58.0M | 1.15% | Reduced −31% |
| INCY Incyte Corporation | 490,422 | $56.8M | 1.13% | Added +100,810% |
| KOD Kodiak Sciences Inc. | 460,421 | $45.1M | 0.90% | New |
| TMO Thermo Fisher Scientific Inc. | 64,754 | $44.6M | 0.89% | Reduced −19% |
| BDX Becton, Dickinson and Company | 206,790 | $44.0M | 0.87% | Added +88% |
| IRON Disc Medicine, Inc. | 560,000 | $42.6M | 0.85% | Unchanged |
| IDXX IDEXX Laboratories, Inc. | 61,487 | $42.4M | 0.84% | Reduced −0% |
| CGON CG Oncology, Inc. | 493,596 | $40.4M | 0.80% | Unchanged |
| AVLN Avalyn Pharma Inc. | 1,350,000 | $38.7M | 0.77% | Unchanged |
| LLY Eli Lilly and Company | 27,481 | $37.1M | 0.74% | Reduced −8% |
| SYRE Spyre Therapeutics, Inc. | 379,870 | $37.1M | 0.74% | Added +65% |
| BSX Boston Scientific Corporation | 827,682 | $35.6M | 0.71% | Reduced −7% |
| ALNY Alnylam Pharmaceuticals, Inc. | 240,322 | $35.5M | 0.71% | Added +21,908% |
| RMD ResMed Inc. | 143,465 | $34.0M | 0.68% | Reduced −3% |
| AXSM Axsome Therapeutics, Inc. | 247,730 | $33.6M | 0.67% | Added +9,113% |
| UNH UnitedHealth Group Incorporated | 97,115 | $32.1M | 0.64% | Reduced −35% |
| ANRO Alto Neuroscience Inc | 1,163,588 | $30.8M | 0.61% | New |
| LBRX LB Pharmaceuticals Inc | 715,513 | $28.6M | 0.57% | New |
| GEHC GE HealthCare Technologies Inc. | 347,192 | $28.4M | 0.57% | Added +37% |
| TNGX Tango Therapeutics, Inc. | 1,099,182 | $25.0M | 0.50% | Added +58% |
| KRYS Krystal Biotech, Inc. | 76,000 | $24.0M | 0.48% | Reduced −2% |
| GKOS Glaukos Corporation | 99,256 | $23.6M | 0.47% | Reduced −23% |
| JNJ Johnson & Johnson | 85,835 | $22.9M | 0.46% | Reduced −17% |
| PVLA Palvella Therapeutics, Inc. | 155,000 | $22.6M | 0.45% | Unchanged |
| SMMT Summit Therapeutics Inc. | 2,113,681 | $22.3M | 0.44% | Added +13,734% |
| DHR Danaher Corporation | 97,509 | $22.2M | 0.44% | Reduced −32% |
| COAG Hemab Therapeutics Holdings, Inc. | 548,935 | $21.9M | 0.43% | Reduced −0% |
| SPTX Seaport Therapeutics, Inc. | 1,100,000 | $20.2M | 0.40% | Unchanged |
| ALGN Align Technology, Inc. | 123,323 | $19.7M | 0.39% | Reduced −12% |
| MRK Merck & Co., Inc. | 132,167 | $17.6M | 0.35% | Added +17% |
| HUM Humana Inc. | 43,320 | $16.5M | 0.33% | Reduced −26% |
| ELV Elevance Health, Inc. | 41,294 | $16.1M | 0.32% | Reduced −27% |
| CI The Cigna Group | 58,171 | $15.9M | 0.32% | Reduced −13% |
| EPRX Eupraxia Pharmaceuticals Inc. | 2,595,139 | $15.9M | 0.32% | New |
| VEEV Veeva Systems Inc. | 59,151 | $15.6M | 0.31% | Reduced −0% |
| ZBH Zimmer Biomet Holdings, Inc. | 146,474 | $14.9M | 0.30% | Added +16% |
| YARW Yarrow Bioscience, Inc. | 1,000,000 | $14.2M | 0.28% | New |
| PBLS Parabilis Medicines, Inc. | 500,000 | $13.8M | 0.27% | Unchanged |
| PRCT PROCEPT BioRobotics Corporation | 502,286 | $12.9M | 0.26% | Unchanged |
| CNC Centene Corporation | 162,015 | $10.6M | 0.21% | Reduced −29% |
| AURA Aura Biosciences, Inc. | 1,418,014 | $9.9M | 0.20% | Added +22% |
| TMDX TransMedics Group, Inc. | 101,139 | $9.5M | 0.19% | Unchanged |
| GMED Globus Medical, Inc. | 133,997 | $9.2M | 0.18% | Reduced −8% |
| THC Tenet Healthcare Corporation | 29,096 | $7.7M | 0.15% | Reduced −25% |
| COO The Cooper Companies, Inc. | 118,919 | $7.2M | 0.14% | Reduced −40% |
| BCAX Bicara Therapeutics Inc. | 720,483 | $6.6M | 0.13% | New |
| HCA HCA Healthcare, Inc. | 13,466 | $6.2M | 0.12% | Reduced −43% |
| NTRA Natera, Inc. | 21,351 | $6.2M | 0.12% | Reduced −14% |
| BMY Bristol-Myers Squibb Company | 105,642 | $6.2M | 0.12% | Added +8,588% |
| PRVA Privia Health Group, Inc. | 248,821 | $6.1M | 0.12% | Added +10% |
| ONC BeOne Medicines AG | 13,785 | $5.5M | 0.11% | Added +32% |
| TXG 10x Genomics, Inc. | 93,900 | $5.4M | 0.11% | Reduced −64% |
| WAY Waystar Holding Corp. | 197,967 | $5.4M | 0.11% | Reduced −33% |
| ABBV AbbVie Inc. | 18,181 | $5.2M | 0.10% | Reduced −55% |
| ILMN Illumina, Inc. | 22,288 | $4.5M | <0.1% | Added +23% |
| MDLN Medline Inc. | 93,317 | $3.5M | <0.1% | Added +14% |
| GMRS GMR Solutions Inc. | 333,333 | $3.3M | <0.1% | Unchanged |
| MCK McKesson Corporation | 2,857 | $3.0M | <0.1% | Reduced −70% |
| ADPT Adaptive Biotechnologies Corporation | 89,439 | $2.5M | <0.1% | Unchanged |
| PRAX Praxis Precision Medicines, Inc. | 6,676 | $2.1M | <0.1% | Added +261% |
| BNTX BioNTech SE | 24,980 | $2.0M | <0.1% | Added +18% |
| SPY State Street SPDR S&P 500 ETF Trust | 2,700 | $1.9M | <0.1% | Unchanged |
| CVS CVS Health Corporation | 21,087 | $1.7M | <0.1% | Reduced −88% |
| PHR Phreesia, Inc. | 140,495 | $1.7M | <0.1% | Unchanged |
| CYTK Cytokinetics, Incorporated | 31,324 | $1.6M | <0.1% | Added +65% |
| OMDA Omada Health, Inc. | 115,450 | $1.4M | <0.1% | Reduced −27% |
| MOBI Mobia Medical, Inc. | 116,874 | $1.4M | <0.1% | Added +17% |
| DFTX Definium Therapeutics, Inc. | 46,456 | $1.4M | <0.1% | Added +454% |
| ALMR Alamar Biosciences, Inc. | 38,025 | $1.1M | <0.1% | Reduced −32% |
| CERT Certara, Inc. | 99,442 | $1.1M | <0.1% | Unchanged |
| TGTX TG Therapeutics, Inc. | 15,843 | $1.0M | <0.1% | New |
| BBNX Beta Bionics, Inc. | 72,152 | $961K | <0.1% | Unchanged |
| BLLN BillionToOne, Inc. | 10,554 | $952K | <0.1% | Unchanged |
| GH Guardant Health, Inc. | 6,196 | $902K | <0.1% | New |
| VTRS Viatris Inc. | 42,003 | $835K | <0.1% | Added +166% |
| PTGX Protagonist Therapeutics, Inc. | 5,375 | $667K | <0.1% | Reduced −90% |
| COGT Cogent Biosciences, Inc. | 22,044 | $612K | <0.1% | Added +353% |
| AMZN Amazon.com, Inc. | 2,198 | $566K | <0.1% | Added +37% |
| MDGL Madrigal Pharmaceuticals, Inc. | 1,329 | $527K | <0.1% | Reduced −72% |
| AAPL Apple Inc. | 1,491 | $521K | <0.1% | Reduced −16% |
| EWTX Edgewise Therapeutics, Inc. | 12,114 | $499K | <0.1% | New |
| GOOG Alphabet Inc. | 1,683 | $456K | <0.1% | New |
| VERA Vera Therapeutics, Inc. | 16,165 | $432K | <0.1% | Reduced −99% |
| EHC Encompass Health Corporation | 3,263 | $432K | <0.1% | Reduced −53% |
| GDX VanEck Gold Miners ETF | 5,750 | $414K | <0.1% | Unchanged |
| LEGN Legend Biotech Corporation | 24,585 | $396K | <0.1% | Reduced −26% |
| CAI Caris Life Sciences, Inc. | 20,191 | $374K | <0.1% | Added +215% |
| GMAB Genmab A/S | 7,064 | $363K | <0.1% | New |
| PFE Pfizer Inc. | 12,367 | $341K | <0.1% | Reduced −68% |
| HALO Halozyme Therapeutics, Inc. | 3,240 | $301K | <0.1% | Reduced −25% |
| ENSG The Ensign Group, Inc. | 1,646 | $291K | <0.1% | New |
| MANE Veradermics Inc | 2,126 | $264K | <0.1% | Reduced −39% |
| RYTM Rhythm Pharmaceuticals, Inc. | 1,992 | $233K | <0.1% | Added +96% |
| ABVX ABIVAX Société Anonyme | 2,786 | $225K | <0.1% | Reduced −56% |
| COR Cencora, Inc. | 640 | $218K | <0.1% | Added +11% |
| AGMB AgomAb Therapeutics NV | 34,836 | $196K | <0.1% | Reduced −29% |
| ABSI Absci Corporation | 23,785 | $194K | <0.1% | New |
| MLYS Mineralys Therapeutics, Inc. | 11,576 | $164K | <0.1% | Added +32% |
| TWST Twist Bioscience Corporation | 1,337 | $149K | <0.1% | New |
| CAH Cardinal Health, Inc. | 531 | $145K | <0.1% | Reduced −38% |
| A Agilent Technologies, Inc. | 815 | $143K | <0.1% | Added +147% |
| MNST Monster Beverage Corporation | 3,092 | $136K | <0.1% | New |
| IQV IQVIA Holdings Inc. | 491 | $123K | <0.1% | Added +68% |
| MBX MBX Biosciences, Inc. | 2,227 | $119K | <0.1% | New |
| TVTX Travere Therapeutics, Inc. | 2,264 | $109K | <0.1% | Reduced −67% |
| MSFT Microsoft Corporation | 172 | $86K | <0.1% | Unchanged |
| APMD Apnimed, Inc. | 4,919 | $85K | <0.1% | New |
| CMPS COMPASS Pathways plc | 9,398 | $81K | <0.1% | New |
| LH Labcorp Holdings Inc. | 182 | $67K | <0.1% | Reduced −35% |
| MTD Mettler-Toledo International Inc. | 36 | $61K | <0.1% | Unchanged |
| NVDA NVIDIA Corporation | 408 | $60K | <0.1% | Unchanged |
| WAT Waters Corporation | 117 | $53K | <0.1% | Reduced −35% |
| ORIC ORIC Pharmaceuticals, Inc. | 5,600 | $43K | <0.1% | New |
| IONS Ionis Pharmaceuticals, Inc. | 1,358 | $37K | <0.1% | Reduced −100% |
| ALMS Alumis Inc. | 8,477 | $37K | <0.1% | New |
| ZTS Zoetis Inc. | 272 | $22K | <0.1% | Reduced −30% |
| ORCL Oracle Corporation | 191 | $21K | <0.1% | Unchanged |
| QCOM QUALCOMM Incorporated | 127 | $21K | <0.1% | Reduced −36% |
| RXRX Recursion Pharmaceuticals, Inc. | 4,627 | $13K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| RARE Ultragenyx Pharmaceutical Inc. | 1,982,775 | $34.1M |
| CLDX Celldex Therapeutics, Inc. | 1,200,000 | $33.6M |
| PODD Insulet Corporation | 127,498 | $17.5M |
| ANNX Annexon, Inc. | 4,100,016 | $14.0M |
| GLUE Monte Rosa Therapeutics, Inc. | 1,190,000 | $10.6M |
| MOH Molina Healthcare, Inc. | 27,761 | $5.6M |
| NBIX Neurocrine Biosciences, Inc. | 24,037 | $3.8M |
| DNLI Denali Therapeutics Inc. | 17,766 | $323K |
| GOOGL Alphabet Inc. | 907 | $247K |
| TEM Tempus AI, Inc. | 3,213 | $192K |
| PTCT PTC Therapeutics, Inc. | 1,626 | $95K |
| GPCR Structure Therapeutics Inc. | 4,762 | $82K |
| ARWR Arrowhead Pharmaceuticals, Inc. | 1,191 | $52K |
| DGX Quest Diagnostics Incorporated | 131 | $34K |